Amfac completes drug wholesaler divestiture
Sale of drug distribution division, Amfac Health Care, to management group for $ 112.4 mil. completed. Price reflects the division's net assets plus a premium of $ 20 mil. Buyout group is led by Amfac Health Care President Melburn Whitmire ("The Pink Sheet" May 16, T&G-4). General Electric Capital is providing $ 150 mil. in revolving credit.
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.